 AUSTIN, Texas, April 1, 2021 PRNewswire -- Aeglea BioTherapeutics, Inc. NASDAQ:AGLE, a clinical-stage biotechnology company developing a new generation of human enzyme therapeutics to benefit people with rare metabolic diseases, today announced it will participate in two virtual investor conferences in April 2021. Conference Details Conference Name: 2021 Virtual Wells Fargo Biotech Corporate Access DayConference Date: Tuesday, April 6 and Thursday, April 8 Participants: Anthony G. 